BioSurface Technologies

Executive Summary

BioSurface Technologies Corporation (BST) is a specialized medical device company founded in 1994 and based in Bozeman, Montana. The company designs, manufactures, and sells a comprehensive range of laboratory equipment, including biofilm reactors and microscopy flow cells, used by researchers to study microbial communities. BST is the sole licensed manufacturer of several industry-standard biofilm reactors developed in collaboration with leading research institutions. With the growing focus on antimicrobial resistance and biofilm-associated infections, BST is well-positioned to benefit from increased demand for biofilm research tools. However, the company remains privately held with limited public financial disclosures, and its growth is tied to research grant cycles and academic budgets. Despite its niche leadership, BST faces competition from larger life sciences tool providers and risks from changes in research funding priorities. Overall, BST represents a steady, specialized player in the biofilm research equipment market with potential for gradual expansion.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation automated biofilm reactor system60% success
• Q2 2026Strategic partnership with a major pharmaceutical company for biofilm drug development services40% success
• TBDFDA registration of a new clinical biofilm diagnostic device30% success